Actively Recruiting
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
Led by Tadashi Watabe · Updated on 2025-07-31
200
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
PET / CT examination using \[18F\] FAPI-74 is performed on patients diagnosed with malignant tumor, and the pathological condition is determined by comparing with FDG-PET/CT examination of conventional diagnostic imaging.
CONDITIONS
Official Title
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with malignant tumors or suspected of having malignant tumors who have had CT or FDG-PET examination
- Patients diagnosed with malignant tumors who are scheduled to receive or have received anticancer treatments such as chemotherapy or radiation therapy
- Patients suspected of recurrence based on clinical findings or diagnostic imaging such as CT or FDG-PET after treatment of malignant tumor
You will not qualify if you...
- Pregnant women or patients who may be pregnant
- Pediatric patients requiring sedation
- Individuals deemed inappropriate as subjects by the study team
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Osaka University Hospital
Suita, Osaka, Japan, 565-0871
Actively Recruiting
Research Team
T
Tadashi Watabe, M.D., Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here